Fig. 1. The effect of JAK-inhibitors on COVID-19 related outcomes.
Risks of A ICU admission; B ARDS; C invasive mechanical ventilation; D interval of hospitalization; E risk of death grouped by agents; F risk of death grouped by the study protocol.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.